Australian Auto Stock News

We note that the Southern Palladium Limited ( ASX:SPD ) Independent Non-Executive Director, Lindiwe Nkosi-Thomas...

Some PLS Group Limited ( ASX:PLS ) shareholders may be a little concerned to see that the MD, CEO & Executive Director...

Wondering whether Greatland Resources at A$13.65 is offering fair value or a mispriced opportunity? This article breaks down what the current share price might be telling you. The stock is up 4.7% over the past week, while the return over the last 30 days is down 2.4% and the year to date move stands at 29.3%. This may signal shifting views on both growth potential and risk. Recent news coverage around Greatland Resources has focused on its position within the broader materials sector and...

Why Aroa Biosurgery’s latest earnings matter for ASX:ARX holders Aroa Biosurgery (ASX:ARX) has drawn fresh attention after reporting full year 2026 results, with sales of NZ$103.85 million and a shift from a net loss to a NZ$4.68 million profit. See our latest analysis for Aroa Biosurgery. The latest earnings announcement follows a strong short-term performance, with a 7 day share price return of 13.33% and a 30 day share price return of 21.43%, even though the share price is down 6.85% year...

Endeavour Group (ASX:EDV) is restructuring its Pinnacle Drinks business, including a review of its winery footprint and operations. The group plans to sell the Oakridge wine brand and exit or sell other non core winery assets. Winery operations are being consolidated to focus on a tighter set of beverage assets within the Pinnacle portfolio. For investors watching Endeavour Group, this reset follows a period of share price weakness. The stock closed at A$2.86, with the share price down 7.4%...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

As Australian shares face a potential retreat, reflecting Wall Street's recent cooling, investors are keenly observing the interplay between local economic indicators and global market trends. In this fluctuating environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those who know the business best.

Nufarm (ASX:NUF) opened H1 2026 with revenue of A$1.7 billion and basic EPS of A$0.07, alongside net income of A$28.0 million. Over the recent half yearly periods, the company has seen revenue move from A$1.8 billion and EPS of A$0.05 in H1 2025 to A$1.6 billion with EPS declining to A$0.54 in H2 2025, before landing at the latest H1 2026 levels. This gives investors a clearer read on how margins are tracking quarter to quarter. Against a backdrop of trailing twelve month losses and analyst...

Fresh from its H1 2026 update, Select Harvests (ASX:SHV) is under the spotlight as you weigh recent revenue and EPS trends against the stock’s A$3.90 share price and what they might signal for profitability. The company has seen half year revenue shift from A$226.4 million in H2 2024 to A$293.8 million in H2 2025, while basic EPS over the same periods moved from A$0.03 to A$0.02, setting up a mixed read on earnings momentum. With trailing 12 month net profit margin at 8.4% versus 8.7% in the...

archTIS Limited ( ASX:AR9 ), might not be a large cap stock, but it led the ASX gainers with a relatively large price...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Insiders who bought Recce Pharmaceuticals Ltd ( ASX:RCE ) stock in the last 12 months were richly rewarded last week...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Australian shares are poised for a slight retreat, influenced by Wall Street's recent cooling and ongoing global economic discussions. Despite the fluctuating market conditions, penny stocks—often overlooked due to their smaller size or newer status—can still present valuable opportunities when backed by solid financials. In this article, we explore several promising Australian penny stocks that combine financial strength with potential for long-term growth.

The Hydration Pharmaceuticals Company Limited's (ASX:HPC) stock rose 33% last week, but insiders who sold US$205m worth...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Retail Food Group Limited's (ASX:RFG) value has fallen 10% in the last week, but insiders who sold AU$523k worth of...

Breville Group Limited ( ASX:BRG ), might not be a large cap stock, but it saw a decent share price growth of 16% on...

As the Australian market holds steady, awaiting key economic data like the anticipated April inflation print, investors are keenly observing how these developments might impact stock valuations. In this environment, identifying stocks trading below their intrinsic value can present opportunities for those looking to capitalize on potential market inefficiencies.

As the Australian market holds steady, awaiting key inflation data, the broader sentiment remains cautious amid global economic shifts and volatile commodity prices. In this environment, identifying promising small-cap stocks requires a keen eye for potential growth drivers and resilience in challenging conditions.

Commonwealth Bank of Australia (ASX:CBA) has appointed Professor Mary-Anne Williams as its first Chief AI Scientist, tasked with overseeing AI research, talent, and implementation across the bank. The bank is trialing an AI-powered customer support agent, Companion, within its app as part of a broader push to embed AI in customer interactions. CEO Matt Comyn has outlined expectations for AI driven workforce changes at CBA and across the wider economy, alongside public engagement on AI with...

Web Travel Group (ASX:WEB) has reported H1 2026 revenue of A$204.6 million with basic EPS of A$0.074, setting a clear snapshot of its recent trading performance. Over the last three reported half years, revenue has moved from A$170.4 million in H1 2025 to A$158 million in H2 2025 and then to A$204.6 million in H1 2026. Over the same periods, basic EPS has shifted from A$0.096 in H1 2025 to a loss of A$0.069 per share in H2 2025 before landing at A$0.074 in the latest period. Together, these...

Aroa Biosurgery (ASX:ARX) has just reported FY 2026 revenue of revenue of NZ$103.9 million and net income of NZ$4.7 million translating to basic EPS of NZ$0.0135. These figures provide a clearer picture of how margins are now flowing through the P&L and what that could mean for the latest print.

Greatland Resources (ASX:GGP) has received all primary environmental approvals for its Havieron gold copper project in Western Australia. The approvals cover both state and federal levels, clearing a key regulatory hurdle for the project. This milestone keeps Havieron on track for a Final Investment Decision targeted for this quarter. For you as an investor, this approval step confirms that Greatland Resources, a gold and copper focused company, can move Havieron further along the...